Biosimilars Market
According to Intent Market Research, the Biosimilars Market is expected to grow from USD 22.2 billion in 2023 at a CAGR of 17.6% to touch USD 69.0 billion by 2030. The Biosimilars Market is dominated by key players such as Amgen Inc., Sandoz International GmbH, Pfizer Inc., Biocon Limited, Celltrion Inc., Samsung Bioepis, Mylan N.V. (Now Viatris), Eli Lilly and Co., Teva Pharmaceutical Industries Ltd., Novartis AG, AbbVie Inc., Merck & Co., Inc., Boehringer Ingelheim GmbH, Stada Arzneimittel AG, Fresenius Kabi AG.